Related Experiment Video
Updated: Jul 14, 2026
13:53
Homogeneous Glycoconjugate Produced by Combined Unnatural Amino Acid Incorporation and Click-Chemistry for Vaccine Purposes
Published on: December 19, 2020
Glycoprotein hormone GalNAc-4-sulphotransferase
1Washington University Medical School, Department of Pathology, St. Louis, MO 63110, U.S.A. Baenziger@pathology.wustl.edu
Biochemical Society Transactions
|March 26, 2003
Summary
A unique carbohydrate structure on glycoprotein hormones like lutropin (LH) is synthesized by GalNAc-4-sulphotransferase 1 (GalNAc-4-ST1). This structure is recognized by a hepatic receptor, mediating LH clearance for reproductive health.
Area of Science:
- Biochemistry
- Glycobiology
- Endocrinology
Background:
- Glycoprotein hormones, including lutropin (LH) and thyrotropin, share conserved terminal carbohydrate structures (SO(4)-4-GalNAcβ1,4GlcNAcβ) across vertebrate species.
- The synthesis of these unique structures involves a specific β1,4GalNAc-transferase and GalNAc-4-sulphotransferase 1 (GalNAc-4-ST1).
- GalNAc-4-ST1 belongs to a family of sulfotransferases, differing from HNK-1-ST by sulfating the C-4 hydroxy group of β1,4-linked GalNAc.
Purpose of the Study:
- To investigate the synthesis and function of the unique terminal GalNAcSO(4) structure on glycoprotein hormones.
- To identify the receptor responsible for recognizing and clearing these sulfated carbohydrate structures.
- To elucidate the role of this recognition and clearance mechanism in regulating hormone levels for reproductive processes.
Main Methods:
- Enzyme assays to characterize GalNAc-4-ST1 activity.
- Analysis of glycoprotein structures and expression patterns.
- Identification and characterization of the mannose/GalNAc-4-SO(4) receptor.
- Studies on hormone clearance kinetics in vivo.
Main Results:
- GalNAc-4-ST1 is highly expressed in the pituitary and brain, mediating the synthesis of terminal GalNAcSO(4) on LH.
- A specific receptor with cysteine-rich domains, located on hepatic endothelial cells, recognizes terminal GalNAc-4-SO(4).
- The receptor functions as a homodimer, binding two GalNAc-4-SO(4) moieties to achieve stable complex formation and mediate LH clearance.
Conclusions:
- The GalNAc-4-ST1 enzyme and its unique sulfated carbohydrate product are crucial for glycoprotein hormone function.
- The hepatic mannose/GalNAc-4-SO(4) receptor plays a vital role in clearing LH from circulation.
- This clearance mechanism, coupled with hormone release, regulates episodic LH secretion essential for reproductive success, such as embryo implantation.
Related Concept Videos
02:50Conjugated Proteins
Simple proteins and protein complexes contain only amino acids. In contrast, many other proteins, called conjugated proteins, covalently bond with non-protein moieties.
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
Nucleoproteins are protein complexes that contain nucleic acids, categorized as deoxyribonucleoproteins (DNPs) or ribonucleoproteins (RNPs) respectively. The nucleosome is a typical example of a DNP where nuclear DNA is associated with histone proteins. The major antigen for the Covid-19 virus SARS-CoV is an RNP that is critical...
01:33Coat Assembly and GTPases
Vesicles incorporate different coat protein subunits in different cell locations, which changes the properties of the coat, such as the shape and geometry of the transport vesicles. Thus, vesicle coat proteins also play a significant role in cargo selection.
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
Coat assembly depends on the local availability of phosphatidylinositol phosphates or PIPs and GTP-binding proteins. Adaptor proteins, which link the coat proteins to the membrane, bind to these PIPs and play a crucial role in controlling...
01:25Protein Glycosylation
Glycosylation, the most common post-translational modification for proteins, serves diverse functions. Adding sugars to proteins makes the proteins more resistant to proteolytic digestion. Glycosylated proteins can act as markers and receptors to promote cell-cell adhesion. Additionally, they have many essential quality control functions in the cell, such as correct protein folding and facilitating transport of misfolded proteins to the cytosol, which can be degraded.
Glycosylation occurs in...
Glycosylation occurs in...
01:24Oligosaccharide Assembly
Protein glycosylation starts in the ER lumen and continues in the Golgi apparatus. Glycosyltransferases catalyze the addition of sugar molecules or glycosylation of proteins. Usually, these enzymes add sugars to the hydroxyl groups of selected serine or threonine residues to form O-linked glycans or the amino groups of asparagine residues to form N-linked glycans. Different positions on the same polypeptide chain can contain differently linked glycans.
Multiple sugar molecules that may or may...
Multiple sugar molecules that may or may...
01:05Proteoglycans
Glycans, a class of complex heterogeneous molecules, can be covalently attached to proteins to form glycosylated proteins that regulate various physiological and pathological processes. Glycosylated proteins or glycoproteins comprise N-linked and O-linked oligosaccharides. O-glycosylation is the most common type of protein glycosylation. Here, glycans attach to the oxygen atom of the hydroxyl groups of Serine or Threonine residues. O-linked glycosylation occurs later in protein processing,...
01:24Glucagon-like Receptor Agonists
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by the...